Upstate Offers New Catch And Release® Immunoprecipitation System
Catch and Release® v2.0 is faster, simpler and more reproducible compared to traditional IP, one of the most common techniques used in biomedical research. The product contains a proprietary resin in a microfuge-compatible spin column, and enables recovery of denatured or non-denatured proteins to overcome many of the drawbacks of traditional bead-based IP. It has been successfully tested on both rabbit and mouse antibodies with a wide variety of lysate preparations from many different cell types.
"One of Upstate's goals is to make our customers' protocols easier, faster and more efficient. By rapidly introducing innovative new products like Catch and Release®, we are seeking to help streamline and standardize routine laboratory techniques to enhance the productivity of our research and drug discovery customers by allowing them to focus on more important elements of their programs," said Ian Ratcliffe, president of Upstate.
Upstate is a leading research discovery provider of the highest quality cell signaling products and services to the life science market. Its customers are biomedical researchers at drug discovery companies and academic institutions in the key disciplines of oncology, immunology, proteomics, cardiology and neurology. Known for its enabling, innovative solutions to help understand the biology of kinases, chromatin, g-proteins and cytokines, Upstate's advanced cell biology tools - drug screening services, enzymes, state specific antibodies, siRNA kits, multiplex assays are used by thousands of customers worldwide, every day to accelerate improving human health.
Upstate, a Serologicals company, is headquartered in Charlottesville, VA, with locations in Lake Placid, NY, and Dundee, Scotland.